About this trial
The investigators would like to evaluate the effect of a multicomponent psychological treatment on fatigue as a symptom of patients with inflammatory bowel diseases (IBD). The intervention will be a combined program consisting of a psychological intervention (Acceptance and Commitment Therapy) and a behavioral intervention (implementation of frequent short naps and graded increase of physical activity). Next to the hypothesized effect on fatigue, the investigators will also measure the effect on fatigability, IBD related disability, anxiety, depression, stress, disease acceptance and perceived control as well as (biomarkers of) disease activity.
Eligibility criteria
Qualifiers
Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures
Males and females 18-70 years old.
Patients with a diagnosis of ulcerative colitis (UC), Crohn's disease (CD), inflammatory bowel disease type unclassified (IBDU) based on radiology, endoscopy and/or histology
Patients with a disease duration of more than one year
Disqualifiers
Patients that initiated new IBD medication (steroids, mesalamine, thiopurines, methotrexate, biologicals or small molecules) in the past three months prior to screening
Patients with objective signs of active disease (CRP<10mg/L or faecal calprotectin <250µg/g) at screening
Participation in an interventional Study with an investigational medicinal product (IMP) or device at screening
Patients with planned surgery at screening
Trial design
Treatments tested in this trial
- Multicomponent psychological intervention
- Early start
- Late start (after 28 weeks)